Navigating GMO Landscape following the EU Clinical Trial Regulation 536/2014 implementation

Join Ergomed regulatory webinar on EU GMO considerations in light of the centralized CTA submission under the EU Clinical Trial Regulation 536/2014. Our expert speakers will guide you through the EU GMO framework, the environmental risk assessments, and the EMA action plan attempting to create an approach to clarify and harmonise national GMO requirements. Don't miss this opportunity to gain profound insights into the forefront of regulatory evolution.